Skip to main content
Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
15.72
+0.07 (0.45%)
At close: Nov 13, 2026, 4:00 PM EST
15.78
+0.06 (0.40%)
After-hours: Nov 13, 2026, 7:30 PM EST

Rallybio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.430.860.64---
Revenue Growth
-35.61%34.91%----
Gross Profit
-5.83-17.54-38.87-53.54--
Operating Income
-21.92-31.36-57.2-78.93-67.88-45.65
Net Income
26.81-8.98-57.78-74.56-66.65-47.01
Earnings Per Share
4.65-1.59-10.61-14.75-16.76-14.74
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
90.6954.7465.51109.93168.99175.33
Total Debt
-0.180.150.390.56-
Net Cash (Debt)
90.6954.5665.36109.54168.44175.33
Net Cash Growth
53.40%-16.52%-40.33%-34.97%-3.93%25.03%
Net Cash Per Share
15.749.6912.0121.6742.3554.97

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
30.99-29.81-49.28-60.27-57.28-45.53
Capital Expenditures
----0.01-0.05-0.33
Free Cash Flow
30.99-29.81-49.28-60.28-57.34-45.87
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-5050.92%-3655.48%-8993.08%---
Pretax Margin
6500.92%-1046.39%-9084.12%---
Profit Margin
6177.42%-1046.39%-9084.12%---
FCF Margin
7139.63%-3474.71%-7748.74%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
195.0133.7862.62---